about
Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activationEfficacy of an oral live vaccine for veterinary use against pseudotuberculosis.Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells.Fast and simple detection of Yersinia pestis applicable to field investigation of plague foci.Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.Oral vaccination against plague using Yersinia pseudotuberculosis.Interleukin 12 exerts a differential effect on the maturation of neonatal and adult human CD45R0- CD4 T cells.Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines.Naive human CD4+ T cells are a major source of lymphotoxin alpha.Enhanced Macrophage M1 Polarization and Resistance to Apoptosis Enable Resistance to Plague.Early systemic bacterial dissemination and a rapid innate immune response characterize genetic resistance to plague of SEG mice.Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia.IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells.Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors.Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.Conformational differences of human IgE on hydrophobic and hydrophilic solid phases detected by monoclonal antibodiesHuman resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigenCorrelation between cell-mediated immunity and degree of infection in subjects living in an endemic area of schistosomiasisDefault development of cloned human naive CD4 T cells into interleukin-4- and interleukin-5- producing effector cellsCD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cellsHuman naive CD4 T cells produce interleukin-4 at priming and acquire a Th2 phenotype upon repetitive stimulations in neutral conditionsRole of interleukin-12 in the maturation of naive human CD4 T cellsIn vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine productionIn vitro maturation of neonatal human CD8 T lymphocytes into IL-4- and IL-5-producing cellsMast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivoCD47 engagement inhibits cytokine production and maturation of human dendritic cellsIL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligationOX40-Mediated cosignal enhances the maturation of naive human CD4+ T cells into high IL-4-producing effectorsYersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnosticsHumoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine
P50
Q28213281-284D2908-FFB6-4242-8732-CAC601C901A8Q33520768-0DD505F3-7040-48F5-BBB0-680EFF61472FQ33854668-1003C452-41E9-4FED-9E77-9C79100907ACQ34575834-E05695F3-EE9F-418D-8727-8BB8CFD8F31EQ35810279-EBA6B550-E19E-4334-825A-55B0365BC9EFQ36804222-F5547D6E-6D9C-4370-AA13-C7408044BB43Q38969819-920E93A5-54A6-4C95-A451-C6E5B4B2549AQ40340770-3D1D467C-1F11-4900-AA12-2887522CB280Q40642148-B9494341-24D4-421B-9602-DFA538584C3BQ40960939-8FCFB375-86F1-4DD0-8700-7EA6AA6618A3Q41355621-22AC9EFB-89FE-4F7A-B340-F14266767013Q41422955-5F340046-38DE-4926-88EB-292F9E79CBCCQ44164203-2066CD33-7B49-4676-A4DB-ED1D55DB8E65Q52061482-0945FD6D-E4B2-4F60-A2F1-6884946293DAQ52904677-9C1BD9E1-3170-496B-BFD8-57F87D2A83F3Q54230753-F323F442-1409-4634-BD3E-5F3587976433Q69014180-1C9DA036-6C69-41D7-B580-D094EC0C5AD3Q70384144-3B96AF5D-0CD3-4860-BCE6-1B12330DD16AQ70526995-20F0DDF0-FD4B-494E-926C-D3AA831CB156Q70911162-3D47EEA2-C6DA-4531-A033-C767E34180B9Q71257858-FBEA3D7B-34F1-4E02-86E0-31975F3B9F0CQ71815237-318A4D9D-5F27-48D5-A01D-E31A4C4393BFQ71871141-0389E2BB-BA0E-41E9-9D84-2F176A77DBE0Q72666665-0ADC7A08-DF4C-423A-A5D0-077B9AB23F15Q72676537-B1E0CA79-EB87-4729-B596-06CB836B8EDEQ72812943-8D8418CC-17DE-4ED0-AB53-97F8FD8A7D9AQ73100796-CBEF7EE9-E0E0-4773-AA76-AAF0527DAAC4Q73407141-A51118F9-28F1-44A1-AB38-4D6492D76254Q77367662-C2537E25-6B76-4116-B0B4-979FF9132653Q77389258-093F49C4-71BC-4795-856B-04C9E9E436D9Q92802444-BA46AACF-3665-49A1-90A9-EAAB152DDDD0Q93357637-5DD4884F-F3B1-4B6D-B2E8-9A12659C9C14
P50
description
researcher
@en
wetenschapper
@nl
name
C Demeure
@ast
C Demeure
@en
C Demeure
@nl
type
label
C Demeure
@ast
C Demeure
@en
C Demeure
@nl
prefLabel
C Demeure
@ast
C Demeure
@en
C Demeure
@nl
P106
P31
P496
0000-0001-7195-1645